Align Technology Cash Flow from Financial Activities 2012-2026 | ALGN

Align Technology annual/quarterly cash flow from financial activities history and growth rate from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
  • Align Technology cash flow from financial activities for the quarter ending March 31, 2026 was $-0.367B, a 140.45% increase year-over-year.
  • Align Technology cash flow from financial activities for the twelve months ending March 31, 2026 was $-1.233B, a 33.12% increase year-over-year.
  • Align Technology annual cash flow from financial activities for 2024 was $-0.356B, a 40.55% decline from 2023.
  • Align Technology annual cash flow from financial activities for 2023 was $-0.598B, a 19.27% increase from 2022.
  • Align Technology annual cash flow from financial activities for 2022 was $-0.502B, a 9.46% increase from 2021.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Align Technology Annual Cash Flow Financial
(Millions of US $)
2024 $-356
2023 $-598
2022 $-502
2021 $-458
2020 $-31
2019 $-486
2018 $-369
2017 $-136
2016 $-96
2015 $-101
2014 $-66
2013 $-38
2012 $10
2011 $27
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.400B $4.035B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00